Tuesday, July 2, 2019

Getting to Know: Cochlear Limited

You could have bought stock in Cochlear Limited at the turn of the century for about $10. A few days ago the stock was worth more than $140 a share.  Cochlear Limited is the biggest of the three companies that dominate the cochlear implant market with about two-thirds of the market. More than a quarter of a million people have a Cochlear implant. Based in Australia, Cochlear Limited does most of its business in Europe and the U.S. through more than a dozen subsidiaries. Its net revenue ios about $220 million. With brands like Nucleus and Baha, more than a quarter of a million people have one of its implants. It employs more than 2800 people.

No comments: